Entrada Therapeutics Reports Second Quarter 2026 Financial Results
Go back to Entrada Therapeutics Reports Second Quarter 2026 Financial Results| (NASDAQ: TRDA) | Delayed: 7.49 -0.11 (1.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.60 | 52 Week High | $ | |||
| Open | $7.64 | 52 Week Low | $ | |||
| Day High | $7.74 | P/E | N/A | |||
| Day Low | $7.49 | EPS | $ | |||
| Volume | 41,815 | |||||

